查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571569

口蹄疫疫苗市场规模：份额，趋势分析报告：按动物、疫苗、通路、地区、细分市场预测，2024-2030年

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

口蹄疫疫苗市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球口蹄疫疫苗市场规模将达到38.8亿美元，2024年至2030年复合年增长率为8.2%。

口蹄疫发病率的增加以及对畜产品国际贸易的社会经济影响正在推动口蹄疫疫苗的需求。此外，由于疫苗的保质期较短，因此往往会被重复购买。

这个市场竞争非常激烈，各政府机构纷纷介入大量购买疫苗。过去几十年来，世界牲畜数量一直在动态增长。在开发中国家，对畜产品的需求不断增加，导致人们对牲畜健康的关注日益增加。对畜产品日益增长的需求彻底改变了全球畜牧业。此外，生活方式改变和人口成长导致的饮食偏好改变等因素预计将推动对畜牧产品的需求。

由于油基疫苗的高效性，越来越多地采用油基疫苗，预计将占据传统疫苗的最大份额。现有的常规疫苗可有效预防临床疾病，但保护时间较短。因此，需要经常接种疫苗作为预防措施。

口蹄疫疫苗市场报告亮点

  • 灭活（灭活）疫苗细分市场占据主导地位，2023 年市场占有率为 53.0%。
  • 牛在 2023 年占据市场主导地位，市场占有率为 53.5%，预计在预测期内将以最快的复合年增长率成长。
  • 预计生猪市场在预测期内将以显着的复合年增长率成长。这是由于猪肉的需求不断增加，因为猪肉是世界上许多开发中国家的良好蛋白质来源和收入来源。
  • 2023年，亚太地区口蹄疫疫苗市场将以48.2%的销售份额占据主导地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 口蹄疫疫苗市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 口蹄疫疫苗市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 口蹄疫疫苗市场：动物估计与趋势分析

  • 细分仪表板
  • 口蹄疫疫苗市场：2023 年和 2030 年动物变化分析
  • 牛
  • 绵羊和山羊
  • 猪
  • 其他的

第五章 口蹄疫疫苗市场：疫苗预估及趋势分析

  • 细分仪表板
  • 口蹄疫疫苗市场：2023年及2030年疫苗波动分析
  • 减毒/活细菌
  • 惰性（死菌）
  • 其他疫苗（DNA疫苗、胜肽疫苗）

第六章 口蹄疫疫苗市场：通路估算及趋势分析

  • 细分仪表板
  • 口蹄疫疫苗市场：2023年及2030年通路波动分析
  • 动物医院/诊所
  • 政府机构
  • 其他的

第七章 口蹄疫疫苗市场：区域估算及趋势分析

  • 2023年及2030年按地区分類的口蹄疫疫苗市场占有率
  • 欧洲
    • 俄罗斯
    • 法国
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 埃及
    • 土耳其

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Merck &Co., Inc.
    • Biogenesis Bago
    • Zoetis Inc.
    • Boehringer Ingelheim International GmbH
    • Indian Immunologicals Limited
    • Bayer AG
    • Hester Biosciences Limited
    • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
    • Brilliant Bio Pharma Limited
    • Biovet Private Ltd
简介目录
Product Code: GVR-1-68038-656-1

Foot And Mouth Disease Vaccine Market Growth & Trends:

The global foot and mouth disease vaccine market size is expected to reach USD 3.88 billion by 2030, registering a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for a lower time period propels the repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as a change in food preferences owing to changing lifestyles coupled with a growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Foot And Mouth Disease Vaccine Market Report Highlights:

  • The inactivated (killed) vaccine segment dominated the market and accounted for a market share of 53.0% in 2023.
  • Cattle dominated the market with a market share of 53.5% in 2023 and is expected to grow at the fastest CAGR over the forecast period.
  • The swine segment is expected to grow at a significant CAGR over the forecast period. It is attributed to the rising demand for pork as it is a good source of protein and income source in many developing countries across the world.
  • Asia Pacific foot & mouth disease vaccine market dominated with a revenue share of 48.2% in 2023 owing to the growing livestock population and high prevalence of FMD in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Foot & Mouth Disease Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Foot & Mouth Disease Vaccine Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Cattle
    • 4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Sheep and Goat
    • 4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Swine
    • 4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Foot & Mouth Disease Vaccine Market: Vaccine Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Modified/ Attenuated Live
    • 5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inactivated (Killed)
    • 5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
    • 5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Foot & Mouth Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Veterinary Hospitals & Clinics
    • 6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Government Institutions
    • 6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Foot & Mouth Disease Vaccine Market: Regional Estimates & Trend Analysis

  • 7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. Europe
    • 7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Russia
      • 7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. France
      • 7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Japan
      • 7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. China
      • 7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. India
      • 7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. South Korea
      • 7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Indonesia
      • 7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. South Korea
      • 7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Thailand
      • 7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Latin America
    • 7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Brazil
      • 7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Argentina
      • 7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Middle East and Africa
    • 7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. South Africa
      • 7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Saudi Arabia
      • 7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. UAE
      • 7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Kuwait
      • 7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Egypt
      • 7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Turkey
      • 7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Merck & Co., Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Biogenesis Bago
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Zoetis Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Boehringer Ingelheim International GmbH
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Indian Immunologicals Limited
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bayer AG
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Hester Biosciences Limited
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Brilliant Bio Pharma Limited
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Biovet Private Ltd
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives